Evidence map›Paper›PMID 35613279›Full record

ArticleScience translational medicine2022

Aberrant methylmalonylation underlies methylmalonic acidemia and is attenuated by an engineered sirtuin.

PamelaSara E Head, Sangho Myung, Yong Chen, Jessica L Schneller, Cindy Wang, Nicholas Duncan, Pauline Hoffman, David Chang, Abigael Gebremariam, Marjan Gucek and 2 more

Open access · greenAbstract read
In one paragraph

Article in Science translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

PamelaSara E HeadNational Institute of General Medical Sciences, NIH, 45 Center Drive, MSC 6200, Bethesda, MD 20892-6200 USA.ORCID 0000-0002-9822-9414
Sangho MyungNational Human Genome Research Institute, NIH, 10 Center Drive, Building 10, Room 7S257, Bethesda, MD 20892, USA.ORCID 0000-0002-3130-247X
Yong ChenNational Heart Lung and Blood Institute, NIH, 31 Center Drive, Building 31, Bethesda, MD 20892, USA.ORCID 0000-0003-1528-3456
Jessica L SchnellerNational Human Genome Research Institute, NIH, 10 Center Drive, Building 10, Room 7S257, Bethesda, MD 20892, USA.ORCID 0000-0002-3325-8599
Cindy WangNational Human Genome Research Institute, NIH, 10 Center Drive, Building 10, Room 7S257, Bethesda, MD 20892, USA.
Nicholas DuncanNational Human Genome Research Institute, NIH, 10 Center Drive, Building 10, Room 7S257, Bethesda, MD 20892, USA.ORCID 0000-0002-1032-4610
Pauline HoffmanNational Human Genome Research Institute, NIH, 10 Center Drive, Building 10, Room 7S257, Bethesda, MD 20892, USA.ORCID 0000-0002-9260-3356
David ChangNational Human Genome Research Institute, NIH, 10 Center Drive, Building 10, Room 7S257, Bethesda, MD 20892, USA.
Abigael GebremariamNational Human Genome Research Institute, NIH, 10 Center Drive, Building 10, Room 7S257, Bethesda, MD 20892, USA.
Marjan GucekNational Heart Lung and Blood Institute, NIH, 31 Center Drive, Building 31, Bethesda, MD 20892, USA.ORCID 0000-0001-7890-2520
Irini ManoliNational Human Genome Research Institute, NIH, 10 Center Drive, Building 10, Room 7S257, Bethesda, MD 20892, USA.ORCID 0000-0003-1543-2941
Charles P VendittiNational Human Genome Research Institute, NIH, 10 Center Drive, Building 10, Room 7S257, Bethesda, MD 20892, USA.ORCID 0000-0001-6599-1253
National Human Genome Research Institute · USNational Heart Lung and Blood Institute · US

Funding

Investigations of Methylmalonic Acidemia and Related DisordersZIAHG200318 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI VENDITTI, CHARLES P · 2009 to 2025
$29.7M
Proteomics CoreZICHL005903 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI GUCEK, MARJAN · 2009 to 2022
$23.3M
Aberrant post-translational modifications characterize the hepatic proteome of methylmalonic acidemiaFI2GM137781 · NIGMS · NATIONAL HUMAN GENOME RESEARCH INST · PI HEAD, PAMELASARA ELBAZ · 2020 to 2020
–
Intramural NIH HHS ZIA HG200318NIGMS NIH HHS FI2 GM137781
6 · The paper itself

Abstract

Organic acidemias such as methylmalonic acidemia (MMA) are a group of inborn errors of metabolism that typically arise from defects in the catabolism of amino and fatty acids. Accretion of acyl-CoA species is postulated to underlie disease pathophysiology, but the mechanism(s) remain unknown. Here, we surveyed hepatic explants from patients with MMA and unaffected donors, in parallel with samples from various mouse models of methylmalonyl-CoA mutase deficiency. We found a widespread posttranslational modification, methylmalonylation, that inhibited enzymes in the urea cycle and glycine cleavage pathway in MMA. Biochemical studies and mouse genetics established that sirtuin 5 (SIRT5) controlled the metabolism of MMA-related posttranslational modifications. SIRT5 was engineered to resist acylation-driven inhibition via lysine to arginine mutagenesis. The modified SIRT5 was used to create an adeno-associated viral 8 (AAV8) vector and systemically delivered to mutant and control mice. Gene therapy ameliorated hyperammonemia and reduced global methylmalonylation in the MMA mice.

Indexed as

Amino Acid Metabolism, Inborn ErrorsSirtuinsAnimalsGenetic TherapyHumansMethylmalonyl-CoA MutaseMiceMethylmalonyl-CoA MutaseSirtuins

Identifiers

PMID35613279
PMCPMC10468269
OpenAlexW4281487571

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.